CTSO
Cytosorbents Crp
5.30$
-3.4%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +29.0% | +102.3% | +63.1% | +51.3% | +12.4% | +73.3% | +1.7% | -13.5% | -10.4% | +14.5% | +4.1% | |
| – | +3.7% | +78.7% | +39.6% | +35.7% | -1.7% | +50.1% | -0.1% | +26.3% | -34.6% | +17.3% | -1.3% | |
| – | +82.3% | +130.7% | +84.9% | +62.3% | +20.7% | +84.4% | +2.3% | -28.7% | +5.9% | +13.4% | +6.4% | |
| – | +59.2% | +23.6% | -15.3% | +90.7% | +56.6% | -27.1% | +85.9% | -7.7% | +3.1% | -51.2% | -33.2% | |
| – | +17.2% | +53.3% | +25.6% | +48.3% | +7.0% | +28.8% | +22.1% | -94.3% | +1,612.2% | -7.6% | +1.9% | |
| – | +34.5% | +41.2% | +12.5% | +60.1% | +21.3% | +12.8% | +33.6% | +0.9% | +3.2% | -23.3% | -1.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -97.0% | +2,392.2% | +223.2% | +95.0% | -29.3% | +16.2% | +232.9% | -96.7% | +19.1% | +786.1% | +86.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.